<DOC>
	<DOCNO>NCT00637728</DOCNO>
	<brief_summary>Purpose study compare effect megestrol acetate concentrate suspension placebo caloric intake treatment cancer-associated anorexia patient lung pancreatic cancer</brief_summary>
	<brief_title>Treatment Cancer-anorexia Using Megestrol Acetate Concentrated Suspension Lung Pancreatic Cancer Patients</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Anorexia</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<mesh_term>Megestrol</mesh_term>
	<mesh_term>Megestrol Acetate</mesh_term>
	<criteria>Stage II , III , IV lung pancreatic cancer Fair , poor , poor appetite Cancer associate anorexia/cachexia Weight loss perceive associate diminished appetite Eastern Cooperative Oncology Group Performance score 0 , 1 , 2 Life expectancy &gt; 3 month Alert mentally competent Women childbearing potential require use adequate reliable method contraception . Postmenopausal woman least 1 year Screening laboratory value must clinically significant ( exception per protocol ) Brain , head neck metastasis may interfere food consumption AIDSrelated wasting Radiation therapy head neck , abdomen , pelvis within past 6 week , anticipated course study result may interfere food consumption Conditions interfere oral intake , ability swallow Absence normally function gut Mechanical obstruction alimentary biliary tract , malabsorption syndrome Intractable frequent vomit regularly interfere eat Clinically significant diarrhea History recurrent thromboembolic event , thromboembolic event past 3 month , longterm anticoagulation treatment thromboembolism Uncontrolled diabetes mellitus , symptomatic hypoadrenalism Poorly control hypertension , congestive heart failure Pregnant/lactating female Use within past 30 day appetite stimulant Use within past week , plan use study parenteral nutrition tube feeding Chronic use steroid within past 3 month ( intermittent shortterm use allow ) Current use willing abstain use illicit substance Allergy , hypersensitivity , contraindication megestrol acetate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Megestrol acetate</keyword>
	<keyword>Anorexia</keyword>
	<keyword>Cachexia</keyword>
	<keyword>Lung cancer</keyword>
	<keyword>Pancreatic cancer</keyword>
	<keyword>Unintended weight loss</keyword>
	<keyword>Body weight</keyword>
	<keyword>Appetite</keyword>
	<keyword>Megace ES</keyword>
</DOC>